Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Modified weekly docetaxel schedule evaluated in elderly breast cancer patients
September 15th, 2005
The safety of a modified weekly docetaxel schedule was evaluated in elderly metastatic breast cancer patients (pts). "Standard dose docetaxel is burdened by severe toxicity. Weekly schedules have been shown to be active as standard scheme with reduced side effects," investigators in Italy reported. "In 20-30% of elderly pts the classic 6-week schedule induces grade 3/4 fatigue and other cumulative toxicities. We carried out this safety study in order to evaluate whether a modified weekly docetaxel schedule would improve the toxicity profile. Twenty-one untreated elderly ({{>=}}70 years) pts suffering from metastatic breast cancer were enrolled in...
Source: Women's Health Weekly (2005-09-15)
|
